Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Capital/Financing Update 2011

May 3, 2011

1643_rns_2011-05-03_8894d687-2fa9-4a2f-844a-2c638aaa4a41.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Paris, May 2, 2011

AMENDMENT TO THE LIQUIDITY CONTRACT WITH EXANE BNP PARIBAS

Sanofi-aventis announced on May 2, 2011 the signature of an amendment to the liquidity contract signed with EXANE BNP PARIBAS on September 16, 2010.

This amendment modifies the resources allocated to the contract which now consist of:

  • 10,000,000 Euros (instead of 40,000,000 Euros initially of which 20,000,000 euros had been made available);
  • Zero Sanofi-aventis shares.

Investor Relations Department Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560 e-mail: [email protected]

Media Relations Department Tel: + 33 1 53 77 44 50 e-mail: [email protected]